Sign Out
Prophylaxis of nausea and vomiting associated with cytotoxic therapy
Adult: 5 mg by slow IV inj over at least 1 min or by IV infusion over 15 min to be given 15 min before chemotherapy on day 1, followed by oral preparation on day 2-6.
Child: >2 yr 0.2 mg/kg (max: 5 mg) by slow IV inj over at least 1 min or by IV infusion at a concentration of 0.05 mg/ mL over 15 min to be given as a single dose before chemotherapy on day 1. >25 kg: Continue once daily at the same dose up to day 5 of chemotherapy.
Child: >2 yr 0.2 mg/kg (max: 5 mg) by slow IV inj over at least 1 min or by IV infusion at a concentration of 0.05 mg/ mL over 15 min to be given as a single dose before chemotherapy on day 1. >25 kg: Continue once daily at the same dose up to day 5 of chemotherapy.
Intravenous
Treatment and prophylaxis of postoperative nausea and vomiting
Adult: 2 mg as single dose or once daily by bolus inj over 30 sec or by IV infusion over 15 min w/in 2 hr at the end of anaesth (treatment) or before induction of anaesth (prophylaxis).
Oral
Prophylaxis of nausea and vomiting associated with cytotoxic therapy
Adult: 5 mg once daily before chemotherapy on day 2-6 following IV dose given on day 1. Duration of treatment: 5 days.
Child: >2 yr 0.2 mg/kg once daily before chemotherapy on day 2-6 following IV dose given on day 1. Duration of treatment: 5 days.
Child: >2 yr 0.2 mg/kg once daily before chemotherapy on day 2-6 following IV dose given on day 1. Duration of treatment: 5 days.
